Vesile Elif Toy1, Serkan Dundar2, Alihan Bozoglan2. 1. Inonu University, Faculty of Dentistry, Department of Periodontology, Malatya, Turkey. 2. Firat University, Faculty of Dentistry, Department of Periodontology, Elazig, Turkey.
Abstract
OBJECTIVE: The aim of this study was to histologically examine the effects of a nonsteroidal anti-inflammatory drug, namely diclofenac sodium (DCS), on the extent of the bone-implant contact (BIC) of titanium implants after four weeks of osseointegration period in a rodent model. MATERIAL & METHODS: Fourteen female Sprague-Dawley rats were divided into two groups: the control (n = 7) and experimental (DCS) groups. Fourteen machine-surfaced titanium implants were placed in the right tibial bones of the rats. The DCS (2 mg/kg) was administered by means of oral gavage to the experimental group for 14 days after four weeks of osseointegration. No medication was administered to the control group throughout the six-week study period. At the end of the study, the rodents were sacrificed and block sections were obtained for histologic evaluation. RESULTS: The mean BIC ratios for the control and DCS groups were 64.15 ± 6.31% and 61.10 ± 6.08%, respectively. No statistically significant difference in terms of the BIC ratios was found between the two groups. CONCLUSION: The results of this study demonstrate that DCS did not impair the BIC of the implants after four weeks of osseointegration.
OBJECTIVE: The aim of this study was to histologically examine the effects of a nonsteroidal anti-inflammatory drug, namely diclofenac sodium (DCS), on the extent of the bone-implant contact (BIC) of titanium implants after four weeks of osseointegration period in a rodent model. MATERIAL & METHODS: Fourteen female Sprague-Dawley rats were divided into two groups: the control (n = 7) and experimental (DCS) groups. Fourteen machine-surfaced titanium implants were placed in the right tibial bones of the rats. The DCS (2 mg/kg) was administered by means of oral gavage to the experimental group for 14 days after four weeks of osseointegration. No medication was administered to the control group throughout the six-week study period. At the end of the study, the rodents were sacrificed and block sections were obtained for histologic evaluation. RESULTS: The mean BIC ratios for the control and DCS groups were 64.15 ± 6.31% and 61.10 ± 6.08%, respectively. No statistically significant difference in terms of the BIC ratios was found between the two groups. CONCLUSION: The results of this study demonstrate that DCS did not impair the BIC of the implants after four weeks of osseointegration.
Authors: Stuart Goodman; Ting Ma; Michael Trindade; Takashi Ikenoue; Ippe Matsuura; Neal Wong; Nora Fox; Mark Genovese; Don Regula; R Lane Smith Journal: J Orthop Res Date: 2002-11 Impact factor: 3.494
Authors: Wei Xin Cai; Li Ma; Li Wu Zheng; Astrid Kruse-Gujer; Stefan Stübinger; Niklaus P Lang; Roger A Zwahlen Journal: Clin Oral Implants Res Date: 2014-03-31 Impact factor: 5.977
Authors: D Chikazu; K Tomizuka; T Ogasawara; H Saijo; T Koizumi; Y Mori; Y Yonehara; T Susami; T Takato Journal: Int J Oral Maxillofac Surg Date: 2007-03-21 Impact factor: 2.789
Authors: Stuart B Goodman; Ting Ma; Lance Mitsunaga; Keita Miyanishi; Mark C Genovese; R Lane Smith Journal: J Biomed Mater Res A Date: 2005-03-01 Impact factor: 4.396
Authors: Fernanda V Ribeiro; João B César-Neto; Francisco H Nociti; Enilson A Sallum; Antonio W Sallum; Sérgio De Toledo; Márcio Z Casati Journal: J Periodontol Date: 2006-10 Impact factor: 6.993
Authors: Rami Alissa; Salah Sakka; Richard Oliver; Keith Horner; Marco Esposito; Helen V Worthington; Paul Coulthard Journal: Eur J Oral Implantol Date: 2009 Impact factor: 3.123